HANSA BIOPHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.8 MXN | -.--% |
|
-.--% | -.--% |
| 31/05 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
| 31/05 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
